|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 45/06 | (2006.01) | ||
| A61K 31/443 | (2006.01) | ||
| A61K 31/47 | (2006.01) |
| (11) | Number of the document | 2914248 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13792149.0 |
| Date of filing the European patent application | 2013-11-01 | |
| (97) | Date of publication of the European application | 2015-09-09 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-05 |
| (46) | Date of publication of the claims translation | 2018-11-26 |
| (86) | Number | PCT/US2013/067952 |
| Date | 2013-11-01 |
| (87) | Number | WO 2014/071122 |
| Date | 2014-05-08 |
| (30) | Number | Date | Country code |
| 201261721622 P | 2012-11-02 | US | |
| 201261728328 P | 2012-11-20 | US | |
| 201361770668 P | 2013-02-28 | US | |
| 201361824005 P | 2013-05-16 | US | |
| 201361840668 P | 2013-06-28 | US |
| (72) |
VERWIJS, Marinus, Jacobus, US
KARKARE, Radhika, US
MOORE, Michael, Douglas, US
|
| (73) |
Vertex Pharmaceuticals Incorporated,
50 Northern Avenue, Boston, MA 02210,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Farmacinės kompozicijos, skirtos CFTR medijuotų ligų gydymui |
| PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CFTR MEDIATED DISEASES |
| Payment date | Validity (years) | Amount | |
| 2025-10-20 | 13 | 289.00 EUR |
| 2026-11-01 |